Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5203844
Max Phase: Preclinical
Molecular Formula: C46H41F3N8O7
Molecular Weight: 874.88
Associated Items:
ID: ALA5203844
Max Phase: Preclinical
Molecular Formula: C46H41F3N8O7
Molecular Weight: 874.88
Associated Items:
Canonical SMILES: CN1CCN(c2ccc(-c3ccc(C(=O)NCc4ccc(CNc5ccc6c(c5)C(=O)N(C5CCC(=O)NC5=O)C6=O)cc4)cc3)cc2NC(=O)c2c[nH]c(=O)cc2C(F)(F)F)CC1
Standard InChI: InChI=1S/C46H41F3N8O7/c1-55-16-18-56(19-17-55)37-13-10-30(20-36(37)53-42(61)34-25-51-40(59)22-35(34)46(47,48)49)28-6-8-29(9-7-28)41(60)52-24-27-4-2-26(3-5-27)23-50-31-11-12-32-33(21-31)45(64)57(44(32)63)38-14-15-39(58)54-43(38)62/h2-13,20-22,25,38,50H,14-19,23-24H2,1H3,(H,51,59)(H,52,60)(H,53,61)(H,54,58,62)
Standard InChI Key: PXGLQUOVJRNPQL-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 874.88 | Molecular Weight (Monoisotopic): 874.3050 | AlogP: 5.01 | #Rotatable Bonds: 11 |
Polar Surface Area: 193.12 | Molecular Species: NEUTRAL | HBA: 10 | HBD: 5 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 10.90 | CX Basic pKa: 7.60 | CX LogP: 3.13 | CX LogD: 2.72 |
Aromatic Rings: 5 | Heavy Atoms: 64 | QED Weighted: 0.11 | Np Likeness Score: -1.07 |
1. Dölle A, Adhikari B, Krämer A, Weckesser J, Berner N, Berger LM, Diebold M, Szewczyk MM, Barsyte-Lovejoy D, Arrowsmith CH, Gebel J, Löhr F, Dötsch V, Eilers M, Heinzlmeir S, Kuster B, Sotriffer C, Wolf E, Knapp S.. (2021) Design, Synthesis, and Evaluation of WD-Repeat-Containing Protein 5 (WDR5) Degraders., 64 (15.0): [PMID:33980013] [10.1021/acs.jmedchem.1c00146] |
Source(1):